维普中文期刊产品整合服务
30篇 您的检索式:作者名="Lode K"
    题名 作者 年代 出处 被引量
1Determination of cefm- enoxime in human body fluids by high - performance liquid chro- matography 显示文摘BORNER K BORNER E LODE H 1983Eur J Clin Microbiol1983,2,1:1
2Risk factors for side effects of isoniazid,rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis显示文摘Schaberg T Rebhan K Lode H 1996Eur Respir J1996,9,10:1
3Choice of psychological coping in laryngectomized, head and neck squamous cell carcinoma patients versus muhiple sclerosis patients 显示文摘Aarstad AK Lode K Larsen JP 2011Eur Arch Otorhino - laryngol2011,268,6:1
4Azithromycin-review of key chemical, phannacokinetic and microbiological features显示文摘Lode H Borner K Koeppe P 1996Journal of Antimicrobial Chemotherapy1996,37,:1
5Risk factors for side - effects of isoniazid, rifampin and pyrazinomide in patients hospitalized for pul- monary tuberculosis 显示文摘Schaberg T Rebhan K Lode H 1996Eur Respir J1996,9,:1
6Illness uncertainty in breast patients:validation of the 5-item short form of the Uncertainty in Illness Scale显示文摘Hagen cancer Mishel 19(2) KB Aas T Lode K 2015Eur J Oncol Nurs2015,,:1
7Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora显示文摘Lode HN Von der Hoh S Ziege K 2001Scand J Infect Dis2001,33,12:1
8Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care 显示文摘Erbes R Oettel K Raffenberg M Mauch H Sehmidt-Ioanas M Lode H 2006Eur Respir J2006,27,6:1
9Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis 显示文摘Schaberg T Rebhan K Lode H 1996Eur Respir J1996,9,10:1
10Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis显示文摘Schaberg T Rebhan K Lode H 1996Fur Respir J1996,9,10:1
11Illness uncertainty in breast cancer patients:validation of the 5-item short form of the Mi- shel uncertainty in illness scale显示文摘Hagen KB Aas T Lode K 2015Eur J Oncol Nuts2015,19,2:1
12Risk factors for side-effects of isoniazid,rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis显示文摘Schaberg T Rebhan K Lode H 1996Eur Respir J1996,9,10:1
13Ankylosing enthesitis,dactylitis,and onychoperiostitis in male DBA/1 mice:a model of psoriatic arthritis显示文摘Lodes RJ Matthys P de Vlam K 2004Ann Rheum Dis2004,63,5:1
14Fabrication of porous scaffolds by three-dimensional plotting of a pasty calcium phosphate bone cement under mild conditions显示文摘Lode A Meissner K Luo Y 2014J Tissue Eng Regen Med2014,8,9:1
15A europium chelate for quantitative point-of-care immunoassays using direct surface measurement 显示文摘yon Lode P Rosenberg J Pettersson K 2003Anal Chem2003,75,13:1
16Determination of linezolid in human serum and urine by high - performance liquid chromatography显示文摘BORNER K BORNER E LODE H 2001lnt J Antim lcrob Agents2001,18,3:1
17Risk factors for side-effects of isoniazid ,rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis显示文摘Schaberg T Rebhan K Lode H 1996Eur Respir J1996,9,:1
18High serum pen- tosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glyeaemic control显示文摘Neumann T Lodes S K/~stner B 2014Osteoporos Int2014,25,5:1
19Risk factors for side-effects of iso- niazid, rlfampin and pyrazinamide in patients hospitalized for pulmo- nary tuberculosis 显示文摘Schaberg T Rebhan K Lode H 1996Eur Respir J1996,9,10:1
20Determination of Gatifloxacin in Human Serum and Urine by HPLC显示文摘Borner K Hartwig H Lode H 2000Chromatogrsphia2000,,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费